SCHEMBL4909342

SCHEMBL4909342

CCOC(=O)c1c(OC)c2ncc(Cc3ccc(F)cc3CNC)cc2n(C)c1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
MEN1 O00255 1/20 0.34
POLB P06746 1/20 0.34
PABPC1 P11940 1/20 0.34
KMT2A Q03164 1/20 0.34
MAPT P10636 4/20 0.34
NPC1 O15118 1/20 0.34
ALPL P05186 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PDE3B Q13370 1/20 0.34
PDE3A Q14432 1/20 0.34
TP53 P04637 2/20 0.34
ALOX5 P09917 1/20 0.34
GRM7 Q14831 1/20 0.34
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14067537 0.93 ALDH1A1 (0.37) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4907852 0.92 ALDH1A1 (0.38) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4900456 0.91 ALDH1A1 (0.33) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4898545 0.91 POLB (0.34) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4907766 0.91 ALDH1A1 (0.36) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4903149 0.91 ALDH1A1 (0.36) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4661974 0.90 KDM4E (0.35) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4660296 0.90 LMNA (0.36) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL4904320 0.90 LMNA (0.33) ALDH1A1KDM4ETSHRMEN1POLB
SCHEMBL14067570 0.89 ALDH1A1 (0.35) ALDH1A1KDM4ETSHRMEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080214527-A1 Hiv Integrase Inhibitors SHIONOGI & CO. LTD (JP) 2008-09-04 US disclosed
US-20080214527-A1 Hiv Integrase Inhibitors SHIONOGI & CO. LTD (JP) 2008-09-04 US disclosed
US-20080214527-A1 Hiv Integrase Inhibitors SHIONOGI & CO. LTD (JP) 2008-09-04 US disclosed
WO-2007019098-A2 HIV INTEGRASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2007-02-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080214527-A1 Hiv Integrase Inhibitors API5, ING2, SAMHD1 ALDH1A1 2874/4885KDM4E 1139/4885TSHR 4605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.